Macrolides
AssigneePfizer Inc.
InventorsLouis Chupak, Mark Flanagan, Takushi Kaneko, Thomas Magee, Mark Noe, Usa Reilly
Life of this patent
Estimating the term…
Abstract
Macrolide compounds per se, as shown below and defined herein, and their use, e.g., as antibacterial and antiprotozoal agents in animals, including humans: Also disclosed are methods of preparing the compounds, intermediates, and pharmaceutical compositions thereof, and methods of treating or preventing disease by administering the compounds to subjects in need. This abstract is only an excerpt and is not limiting of the invention.
Claims5
1-38. (canceled)
3-descladinosyl-11,12-dideoxy-6-O-methyl-3-oxo-12,11-(oxycarbonyl-(1-(1R-(1,8-naphthyridin-4-yl)-ethyl)-azetidin-3-yl)-imino)-erythromycin A.
Dependencies are inferred from the claim text.